Celldex Therapeutics, Inc.【CLDX】 業績・財務データ
市場
NASDAQ
| （単位：百万ドル） | 2011/12/31 | 2012/12/31 | 2013/12/31 | 2014/12/31 | 2015/12/31 | 2016/12/31 | 2017/12/31 | 2018/12/31 | 2019/12/31 | 2020/12/31 | 2021/12/31 | 2022/12/31 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | 3 | 0 | 2 | 0 | 0 | ||||||||
| Grant | 6 | 3 | 5 | 5 | 2 | ||||||||
| Total revenues | |||||||||||||
| Research and development | |||||||||||||
| General and administrative | |||||||||||||
| Intangible asset impairment | |||||||||||||
| Gain on fair value remeasurement of contingent consideration | |||||||||||||
| Litigation settlement related loss | |||||||||||||
| Total operating expenses | |||||||||||||
| Operating loss | |||||||||||||
| Interest and Other Income | |||||||||||||
| Net loss before income tax benefit | |||||||||||||
| Income tax benefit | |||||||||||||
| Net loss | |||||||||||||
| Earnings Per Share, Basic | |||||||||||||
| Earnings Per Share, Diluted | |||||||||||||
| Net loss | |||||||||||||
| Unrealized loss on marketable securities | |||||||||||||
| Comprehensive loss | |||||||||||||
Powered by Ponder (兄弟サイト)
アプリでもっと便利に
© 2016-2023 Strainer